Wells Fargo Initiates Savara(SVRA.US) With Buy Rating, Announces Target Price $8
Wells Fargo Initiates Coverage On Savara With Overweight Rating, Announces Price Target of $8
Savara Analyst Ratings
JMP Securities Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $9
JMP Securities Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $9
Savara Positioned for Success: Buy Rating Boosted by Strong BLA Progress and Market Potential for Molbreevi
Savara Is Maintained at Buy by HC Wainwright & Co.
Oppenheimer Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $15
Oppenheimer Keeps Their Buy Rating on Savara (SVRA)
H.C. Wainwright Maintains Savara(SVRA.US) With Buy Rating, Cuts Target Price to $6
Evercore Downgrades Savara(SVRA.US) to Hold Rating, Cuts Target Price to $5
Savara Price Target Cut to $5.00/Share From $7.00 by Evercore ISI Group
Savara Cut to In-Line From Outperform by Evercore ISI Group
Savara Analyst Ratings
Evercore ISI Downgrades Savara (SVRA) to a Hold
Savara's Promising Molbreevi Launch: Buy Rating Backed by Strategic Initiatives and IMPALA-2 Trial Success
Piper Sandler Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $16
H.C. Wainwright Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $10
Piper Sandler Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $16
H.C. Wainwright Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $10